Virtual Screening

. Ed(s): Klebe, Gerhard

ISBN 10: 0792366336 ISBN 13: 9780792366331
Edité par Kluwer Academic Publishers, 2000
Neuf(s) Couverture rigide

Vendeur Kennys Bookstore, Olney, MD, Etats-Unis Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Vendeur AbeBooks depuis 9 octobre 2009


A propos de cet article

Description :

The first workshop on new approaches in drug design and discovery was held in March 1999, at Schloss Rauischholzhausen, near Marburg in Germany. The speakers were invited to summarize their contributions together with their impressions on the applicability of their approach. This title summerizes this request. Editor(s): Klebe, Gerhard. Num Pages: 295 pages, 35 black & white illustrations, 18 colour illustrations, biography. BIC Classification: MJA; MMG; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 19. Weight in Grams: 688. . 2000. Reprinted from perspectives in drug discovery and. Hardback. . . . . Books ship from the US and Ireland. N° de réf. du vendeur V9780792366331

Signaler cet article

Synopsis :

In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design.
As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloß Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this requestwhich is summarized in this publication.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Détails bibliographiques

Titre : Virtual Screening
Éditeur : Kluwer Academic Publishers
Date d'édition : 2000
Reliure : Couverture rigide
Etat : New

Meilleurs résultats de recherche sur AbeBooks

Image d'archives

Edité par Springer, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Ancien ou d'occasion Couverture rigide

Vendeur : Ammareal, Morangis, France

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Hardcover. Etat : Très bon. Ancien livre de bibliothèque. Edition 2000. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 2000. Ammareal gives back up to 15% of this item's net price to charity organizations. N° de réf. du vendeur E-985-250

Contacter le vendeur

Acheter D'occasion

EUR 5,84
Expédition à EUR 16,50
Expédition depuis France vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image d'archives

Unbekannt
Edité par Springer, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Ancien ou d'occasion Couverture rigide

Vendeur : Buchpark, Trebbin, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : Sehr gut. Zustand: Sehr gut | Seiten: 295 | Sprache: Englisch | Produktart: Bücher | In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design. As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloß Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this requestwhich is summarized in this publication. N° de réf. du vendeur 3035648/12

Contacter le vendeur

Acheter D'occasion

EUR 29,90
Expédition à EUR 105
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Neuf Couverture rigide

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. In. N° de réf. du vendeur ria9780792366331_new

Contacter le vendeur

Acheter neuf

EUR 162,66
Expédition à EUR 13,83
Expédition depuis Royaume-Uni vers Etats-Unis

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Klebe, Gerhard
Edité par Springer Netherlands, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Neuf Couverture rigide

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Gebunden. Etat : New. In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful . N° de réf. du vendeur 5969571

Contacter le vendeur

Acheter neuf

EUR 178,14
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Gerhard Klebe
Edité par Kluwer Academic Pub, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Neuf Couverture rigide

Vendeur : Revaluation Books, Exeter, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Hardcover. Etat : Brand New. 295 pages. 9.75x6.75x0.75 inches. In Stock. N° de réf. du vendeur x-0792366336

Contacter le vendeur

Acheter neuf

EUR 233,25
Expédition à EUR 14,43
Expédition depuis Royaume-Uni vers Etats-Unis

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Gerhard Klebe
Edité par Springer Nov 2000, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Neuf Couverture rigide

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Neuware - In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design. As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloß Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this requestwhich is summarized in this publication. N° de réf. du vendeur 9780792366331

Contacter le vendeur

Acheter neuf

EUR 247,94
Expédition à EUR 63,46
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2000
ISBN 10 : 0792366336 ISBN 13 : 9780792366331
Ancien ou d'occasion Couverture rigide

Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

Hardcover. Etat : Like New. Like New. book. N° de réf. du vendeur ERICA77307923663366

Contacter le vendeur

Acheter D'occasion

EUR 272,32
Expédition à EUR 28,86
Expédition depuis Royaume-Uni vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier